当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析

泰格医药

(300347)

  

流通市值:285.28亿  总市值:434.90亿
流通股本:5.67亿   总股本:8.65亿

泰格医药(300347)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润9.03亿元,每股收益0.94元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益2441879.92万元,未分配利润909693.29万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产3027659.20万元,负债585779.29万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入5,067,615,359.893,358,244,223.391,660,204,321.447,384,039,460.88
营业总成本4,026,550,519.062,626,269,846.321,305,287,804.375,554,124,713.54
营业利润1,084,995,900.89687,069,420.22362,196,228.412,486,940,557.42
利润总额1,087,064,971.75690,093,172.97362,364,203.952,488,533,058.16
净利润903,135,476.96557,578,693.92312,570,373.392,149,926,843.57
其他综合收益-50,709,884.36-30,370,935.25-22,239,213.9153,516,065.69
综合收益总额852,425,592.6527,207,758.67290,331,159.482,203,442,909.26
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计6,547,520,834.957,646,634,878.711,661,670,938.8311,344,141,125.21
非流动资产合计23,729,071,186.3522,770,481,531.1418,408,514,552.3418,336,601,223.96
资产总计30,276,592,021.330,417,116,409.8430,070,185,491.1729,680,742,349.17
流动负债合计4,795,257,756.835,332,415,803.114,463,914,497.714,138,736,291.58
非流动负债合计1,062,535,113.271,017,224,456.841,072,979,118.961,088,443,912.33
负债合计5,857,792,870.16,349,640,259.955,536,893,616.675,227,180,203.91
归属于母公司股东权益合计21,064,966,698.7520,765,168,106.1421,131,829,587.0521,026,774,725.75
股东权益合计24,418,799,151.224,067,476,149.8924,533,291,874.524,453,562,145.26
负债和股东权益合计30,276,592,021.330,417,116,409.8430,070,185,491.1729,680,742,349.17
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计4,993,719,526.643,167,414,281.91,549,726,817.367,095,305,409.42
经营活动现金流出小计4,414,949,916.692,990,085,897.191,405,522,357.295,944,867,467.37
经营活动产生的现金流量净额578,769,609.95177,328,384.71144,204,460.071,150,437,942.05
投资活动现金流入小计667,411,884.05313,942,039.75162,647,537.341,293,893,974.05
投资活动现金流出小计6,390,528,783.584,935,752,742.45282,364,101.452,828,118,716.52
投资活动产生的现金流量净额-5,723,116,899.53-4,621,810,702.7-119,716,564.11-1,534,224,742.47
筹资活动现金流入小计3,012,671,977.211,601,118,629.06447,503,471.273,596,068,529.07
筹资活动现金流出小计3,284,673,663.161,394,908,618.55445,078,699.33,603,874,589.35
筹资活动产生的现金流量净额-272,001,685.95206,210,010.512,424,771.97-7,806,060.28
汇率变动对现金及现金等价物的影响-21,705,538.241,473,866.18-5,074,061.178,793,343.53
现金及现金等价物净增加额-5,438,054,513.77-4,236,798,441.321,838,606.76-382,799,517.17
期末现金及现金等价物余额1,961,886,856.083,163,142,928.557,421,779,976.617,399,941,369.85
最新报告期:2024-12-27
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
中信证券陈竹1.561.812.262024-12-27
中信证券陈竹1.692.002.422024-11-26
招商证券许菲菲1.391.672.022024-11-08
TOP↑